AU2513592A - Hepatitis c assay utilizing recombinant antigens to ns1 - Google Patents

Hepatitis c assay utilizing recombinant antigens to ns1

Info

Publication number
AU2513592A
AU2513592A AU25135/92A AU2513592A AU2513592A AU 2513592 A AU2513592 A AU 2513592A AU 25135/92 A AU25135/92 A AU 25135/92A AU 2513592 A AU2513592 A AU 2513592A AU 2513592 A AU2513592 A AU 2513592A
Authority
AU
Australia
Prior art keywords
ala
val
leu
gly
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25135/92A
Other languages
English (en)
Inventor
Stephen H. Dailey
Suresh M. Desai
Sushil G. Devare
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU2513592A publication Critical patent/AU2513592A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU25135/92A 1991-08-21 1992-08-21 Hepatitis c assay utilizing recombinant antigens to ns1 Abandoned AU2513592A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74856191A 1991-08-21 1991-08-21
US748561 1991-08-21

Publications (1)

Publication Number Publication Date
AU2513592A true AU2513592A (en) 1993-03-16

Family

ID=25009968

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25135/92A Abandoned AU2513592A (en) 1991-08-21 1992-08-21 Hepatitis c assay utilizing recombinant antigens to ns1

Country Status (6)

Country Link
EP (1) EP0600009A4 (cg-RX-API-DMAC7.html)
JP (1) JPH06510191A (cg-RX-API-DMAC7.html)
AU (1) AU2513592A (cg-RX-API-DMAC7.html)
CA (1) CA2115926A1 (cg-RX-API-DMAC7.html)
TW (1) TW213924B (cg-RX-API-DMAC7.html)
WO (1) WO1993004088A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6762024B2 (en) * 1993-04-27 2004-07-13 Innogenetics, S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
ES2197170T3 (es) * 1993-11-04 2004-01-01 Innogenetics N.V. Epitopos de celulas t humanas inmunologicamente dominantes del virus de la hepatitis c.
US5610009A (en) * 1994-01-28 1997-03-11 Abbott Laboratories Mammalian expression systems for hepatitis C virus envelope genes
EP1845108A3 (en) * 1994-07-29 2007-10-24 Innogenetics N.V. Monoclonal antibodies to purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
US6329157B1 (en) 1998-05-28 2001-12-11 Abbott Laboratories Antigen cocktails and uses thereof
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
US8124747B2 (en) 2003-08-29 2012-02-28 Innogenetics HCV clade and prototype sequences thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989004669A1 (en) * 1987-11-18 1989-06-01 Chiron Corporation Nanbv diagnostics and vaccines
US5124255A (en) * 1988-03-11 1992-06-23 Abbott Laboratories CKS method of protein synthesis
HUT54896A (en) * 1989-03-17 1991-04-29 Chiron Corp Process for producing aquous diagnosticum and vaccine of nanbv
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV

Also Published As

Publication number Publication date
EP0600009A4 (en) 1995-03-01
WO1993004088A1 (en) 1993-03-04
CA2115926A1 (en) 1993-03-04
JPH06510191A (ja) 1994-11-17
EP0600009A1 (en) 1994-06-08
TW213924B (cg-RX-API-DMAC7.html) 1993-10-01

Similar Documents

Publication Publication Date Title
US5871903A (en) HCV isolates
Falgout et al. Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity
US6593083B1 (en) Hepatitis C assay utilizing recombinant antigens
ES2141081T5 (es) Nuevo aislado de hcv j-1.
EP0472207B1 (en) Hepatitis C assay utilizing recombinant antigens
CN100365017C (zh) 肺炎衣原体抗原多肽
CA2005950C (en) Non-a, non-b hepatitis virus genome rna, cdna and virus antigen protein
Pilot‐Matias et al. Identification of antigenic regions in the GB hepatitis viruses GBV‐A, GBV‐B, and GBV‐C
AU716379B2 (en) Methodology to produce, purify and assay polypeptides with the proteolytic activity of the HCV NS3 protease
EP1227323B1 (en) Non-A, non-B hepatitis virus antigen, and diagnostic methods
Pereboeva et al. Hepatitis C epitopes from phage‐displayed cDNA libraries and improved diagnosis with a chimeric antigen
WO1993004088A1 (en) Hepatitis c assay utilizing recombinant antigens to ns1
CN101784561A (zh) 用于诊断或筛选节肢介体病毒感染的方法、在所述方法和它们的应用中使用的试剂
Shoji et al. Proteolytic activity of NS3 serine proteinase of hepatitis C virus efficiently expressed in Escherichia coli
CA2070952A1 (en) Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same
US5800982A (en) Antigenic peptides for growing hepatitis C virus, kit comprising the same and methods for its grouping using the same
EP0600000A1 (en) Hepatitis c assay utilizing recombinant antigens from ns5 region
CA2116026C (en) Hepatitis c assay utilizing recombinant antigens to c-100 region
Gwack et al. NTPase activity of hepatitis C virus NS3 protein expressed in insect cells
Khanna et al. Hepatitis C virus core protein: synthesis, affinity purification and immunoreactivity with infected human sera
JPH06507552A (ja) 肝炎疾患の診断において有用なdna配列及びコードされたポリペプチド
Seki et al. Effective production of the hepatitis C virus core antigen having high purity in Escherichia coli
US7491808B2 (en) HCV non-structural protein mutants and uses thereof
US6030771A (en) Mosaic protein and restriction endonuclease assisted ligation method for making the same
JP3669717B2 (ja) C型肝炎ウイルスのグルーピングのための抗原性ペプチド、それを含有するキットおよびそれを使用するグルーピング方法